176 related articles for article (PubMed ID: 35257069)
1. A Diverse Spectrum of Immune Complex- and Complement-Mediated Kidney Diseases Is Associated With Mantle Cell Lymphoma.
Andeen NK; Abdulameer S; Charu V; Zuckerman JE; Troxell M; Kambham N; Alpers CE; Najafian B; Nicosia RF; Smith KD; Kung VL; Avasare RS; Vallurupalli A; Jefferson JA; Hecox D; Swetnam L; Yamashita M; Lin M; Bissonnette ML; Akilesh S; Hou J
Kidney Int Rep; 2022 Mar; 7(3):568-579. PubMed ID: 35257069
[TBL] [Abstract][Full Text] [Related]
2. Demographic, clinical characteristics and treatment outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulonephritis in Japan: A retrospective analysis of data from the Japan Renal Biopsy Registry.
Nakagawa N; Mizuno M; Kato S; Maruyama S; Sato H; Nakaya I; Sugiyama H; Fujimoto S; Miura K; Matsumura C; Gotoh Y; Suzuki H; Kuroki A; Yoshino A; Nakatani S; Hiromura K; Yamamoto R; Yokoyama H; Narita I; Isaka Y
PLoS One; 2021; 16(9):e0257397. PubMed ID: 34520493
[TBL] [Abstract][Full Text] [Related]
3. Parenchymal infiltration and lymphoma-associated membranoproliferative pattern of glomerular injury: an unusual presentation of mantle cell lymphoma.
Sekulic M; Stanek J; Crosson JT; Kim Y; Dolan M; Krigman HR; Linden MA
Clin Nephrol; 2015 Sep; 84(3):173-80. PubMed ID: 26226946
[TBL] [Abstract][Full Text] [Related]
4. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective.
Bridoux F; Javaugue V; Nasr SH; Leung N
Nephrol Dial Transplant; 2021 Jan; 36(2):208-215. PubMed ID: 33494099
[TBL] [Abstract][Full Text] [Related]
5. Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.
Zand L; Lorenz EC; Cosio FG; Fervenza FC; Nasr SH; Gandhi MJ; Smith RJ; Sethi S
J Am Soc Nephrol; 2014 May; 25(5):1110-7. PubMed ID: 24357668
[TBL] [Abstract][Full Text] [Related]
6. Standardized classification and reporting of glomerulonephritis.
Sethi S; Fervenza FC
Nephrol Dial Transplant; 2019 Feb; 34(2):193-199. PubMed ID: 30124958
[TBL] [Abstract][Full Text] [Related]
7. Etiology and Outcome of Crescentic Glomerulonephritis From a Single Center in China: A 10-Year Review.
Chen S; Tang Z; Xiang H; Li X; Chen H; Zhang H; Hu W; Zeng C; Liu Z
Am J Kidney Dis; 2016 Mar; 67(3):376-83. PubMed ID: 26388283
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Challenges and Emerging Pathogeneses of Selected Glomerulopathies.
Andeen NK; Hou J
Pediatr Dev Pathol; 2024 Apr; ():10935266241237656. PubMed ID: 38576387
[TBL] [Abstract][Full Text] [Related]
9. C3 glomerulonephritis associated with monoclonal gammopathy: a case series.
Zand L; Kattah A; Fervenza FC; Smith RJ; Nasr SH; Zhang Y; Vrana JA; Leung N; Cornell LD; Sethi S
Am J Kidney Dis; 2013 Sep; 62(3):506-14. PubMed ID: 23623956
[TBL] [Abstract][Full Text] [Related]
10. C3 glomerulonephritis associated with ANCA positivity: a case report.
Li L; Liu LQ; Yang YY; Hu ZX
BMC Nephrol; 2021 Apr; 22(1):143. PubMed ID: 33882866
[TBL] [Abstract][Full Text] [Related]
11. A Case of Switch from C3 Glomerulonephritis to Proliferative Glomerulonephritis with Monoclonal IgG Deposits.
Zhang F; Gao E; Liang S; Yang N; Wang J
Ann Clin Lab Sci; 2018 Jul; 48(4):528-533. PubMed ID: 30143498
[TBL] [Abstract][Full Text] [Related]
12. A case of C3 glomerulonephritis successfully treated with eculizumab.
Payette A; Patey N; Dragon-Durey MA; Frémeaux-Bacchi V; Le Deist F; Lapeyraque AL
Pediatr Nephrol; 2015 Jun; 30(6):1033-7. PubMed ID: 25796589
[TBL] [Abstract][Full Text] [Related]
13. C4d as a Diagnostic Tool in Proliferative GN.
Sethi S; Nasr SH; De Vriese AS; Fervenza FC
J Am Soc Nephrol; 2015 Nov; 26(11):2852-9. PubMed ID: 25991041
[TBL] [Abstract][Full Text] [Related]
14. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
Sethi S; Fervenza FC; Zhang Y; Zand L; Vrana JA; Nasr SH; Theis JD; Dogan A; Smith RJ
Kidney Int; 2012 Aug; 82(4):465-73. PubMed ID: 22673887
[TBL] [Abstract][Full Text] [Related]
15. Proliferative glomerulonephritis associated with monoclonal immune deposits: A case report and review of literature.
Fatima R; Jha R; Gowrishankar S; Narayen G; Rao BS
Indian J Nephrol; 2014 Nov; 24(6):376-9. PubMed ID: 25484532
[TBL] [Abstract][Full Text] [Related]
16. C3 glomerulopathy: clinicopathologic features and predictors of outcome.
Medjeral-Thomas NR; O'Shaughnessy MM; O'Regan JA; Traynor C; Flanagan M; Wong L; Teoh CW; Awan A; Waldron M; Cairns T; O'Kelly P; Dorman AM; Pickering MC; Conlon PJ; Cook HT
Clin J Am Soc Nephrol; 2014 Jan; 9(1):46-53. PubMed ID: 24178974
[TBL] [Abstract][Full Text] [Related]
17. Proliferative Glomerulonephritis With Fibrils, Monoclonal κ Light Chain, and C3 Deposits.
Steinberg AG; Fox LC; Bender S; Batrouney A; Juneja S; Sirac C; Touchard G; Blombery P; Finlay MJ; Bridoux F; Barbour TD
Am J Kidney Dis; 2021 Sep; 78(3):459-463. PubMed ID: 33774080
[TBL] [Abstract][Full Text] [Related]
18. A case of recurrent proliferative glomerulonephritis with monoclonal IgG deposits or de novo C3 glomerulonephritis after kidney transplantation.
Tamura T; Unagami K; Okumi M; Kakuta Y; Horita S; Ishida H; Koike J; Honda K; Tanabe K; Nitta K
Nephrology (Carlton); 2018 Jul; 23 Suppl 2():76-80. PubMed ID: 29968411
[TBL] [Abstract][Full Text] [Related]
19. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits triggered by COVID-19: a case report.
Shieh M; Giannini JA; Combs SA; Shaffi SK; Messias NC; Teixeira JP
CEN Case Rep; 2022 Aug; 11(3):380-385. PubMed ID: 35122206
[TBL] [Abstract][Full Text] [Related]
20. Pathology after eculizumab in dense deposit disease and C3 GN.
Herlitz LC; Bomback AS; Markowitz GS; Stokes MB; Smith RN; Colvin RB; Appel GB; D'Agati VD
J Am Soc Nephrol; 2012 Jul; 23(7):1229-37. PubMed ID: 22677550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
